Daewoong Pharmaceutical Co. Ltd.

This study tested a new triple therapy (DWP14012-based) against a standard therapy for eradicating H. pylori, a stomach bacteria that can cause ulcers. 461 adults with confirmed H. pylori infection participated. The goal was to see if the new treatment was as effective and safe a…

This study tested whether adding a third drug (DWC202314) to a two-drug combination (DWC202405/DWC202313) works better for people whose high blood pressure is not controlled by the two drugs alone. 198 adults with essential hypertension took part. The main goal was to see if the …

This study tested whether adding a second drug (DWC202314) to an existing one (DWC202404) can lower blood pressure more effectively in people whose blood pressure remains high on just one medication. 192 adults with essential hypertension took part. The goal was to see if the com…

This study tested whether taking two medications together (DWC202206 and DWC202207) is safe and effective for people with both high blood pressure and high cholesterol. 214 adults aged 19 to 80 took part. The goal was to see if the combination lowered blood pressure and LDL (bad)…

This study looked at how well FEXUCLUE tablets improve symptoms like heartburn and acid reflux in people with erosive gastroesophageal reflux disease (GERD). Over 2,800 adults took the medicine for 4 to 8 weeks and reported their symptom changes. The goal was to see if the drug h…

This study looked at how two experimental drugs (DWC202511 and DWC202512) change the way the body processes another drug (DWP16001) in 18 healthy adults aged 19 to 50. Participants took the drugs in a fixed order, and researchers measured drug levels in the blood. The goal was to…

This study checked whether two drugs, DWJ1445 and DWC202506, are absorbed and processed by the body in the same way. It involved 70 healthy adults who took a single dose of each drug at different times. The goal was to measure drug levels in the blood, not to treat any disease.